引用本文
  • 康宝丽,陆英 综述,徐增光审校.Toll样受体在肺癌中的研究进展[J].同济大学学报(医学版),2015,36(3):140-144.    [点击复制]
  • KANG Bao-li,LU Ying,XU Zeng-guang.Research progress of Toll-like receptor in lung cancer[J].同济大学学报(医学版),2015,36(3):140-144.   [点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 437次   下载 481 本文二维码信息
码上扫一扫!
Toll样受体在肺癌中的研究进展
康宝丽,陆英综述,徐增光审校
0
(同济大学附属东方医院科研部,上海 200120)
摘要:
肺癌是目前全世界癌症死因的第一位。尽管治疗在不断进步,但预后仍然很差。Toll样受体(Toll-like receptors, TLRs)是一种模式识别受体,是非常重要的天然免疫分子。TLRs识别特异性分子以后能调节适应性免疫。通过TLRs激活免疫系统在起到抗肿瘤作用的同时,由于潜在的慢性炎症,又促进了肺癌的进程。越来越多的研究发现TLRs在肺癌中的功能及其分子机制,提示TLRs在肺癌发生、发展中具有重要作用。
关键词:  Toll样受体  炎症  肺肿瘤  免疫系统
DOI:10.16118/j.1008-0392.2015.03.031
投稿时间:2014-06-26
基金项目:上海市浦东新区卫生系统领先人才培养计划(PWRL2014-01); 上海市浦东新区科委(PKJ2009-Y05); 上海市科委生物医药领域重点项目(11DZ1973800)
Research progress of Toll-like receptor in lung cancer
KANG Bao-li,LU Ying,XU Zeng-guang
(Dept. of Research, East Hospital, Tongji University, Shanghai 200120, China)
Abstract:
Lung carcinoma is one of the leading causes of death worldwide. Despite advances in treatment, the prognosis remains poor.Toll-like receptors play a key role in the innate immune system. The recognition of specific molecules by TLRs leads to the activation of the adaptive immune system. The exogenous activation of the immune system via TLRs could on one side be a strategy to fight cancer, but on the other exacerbate, a latent chronic inflammation, which in turn, would further favour lung carcinoma progression. Recently, evidence has been accumulated to illustrate the molecular mechanisms by which these TLRs are functioning, so that to provide insight into the functional roles they may play in tumorigenesis.
Key words:  Toll-like receptors  inflammation  lung cancer  immune system

您是第5110005位访问者
版权所有《同济大学学报(医学版)》编辑部
主管单位:教育部 主办单位:同济大学
地  址: 上海四平路1239号 邮编:200092 电话:021-65980705 E-mail: yxxb@tongji.edu.cn
本系统由北京勤云科技发展有限公司设计